Date posted 2 February 2021
Applications close 15 March 2021
The TTRA Research Centres will accelerate therapies towards clinical practice for the prevention, diagnosis, treatment and management of disease-related complications for identified priorities associated with diabetes or cardiovascular disease, respectively.
Each Research Centre will be funded to a maximum of $10 million over four years. Partnerships and co-contributions are strongly encouraged and investigation in diverse clinical and therapeutic treatment modalities will be viewed favourably.
Each Research Centre must focus on at least two of the identified Priority Areas, with favourable recognition given to proposals addressing all three Priority Areas.
The Diabetes Research Centre’s translational research, development and implementation science activities must address at least two of the following Priority Areas:
The Cardiovascular Disease Research Centre’s translational research, development and implementation science activities must address at least two of the following Priority Areas:
The Research Centres must also demonstrate how adoption and implementation of their therapies will subsequently deliver health system outcomes, public health policy outcomes, consumer outcomes, commercial outcomes and reduce the burden of disease and health inequalities in Australia. It is expected that each Research Centre will have a strategy to become sustainable to ensure continued financial viability and talent management of the entity beyond the four years of TTRA funding. In addition to research and development, each Research Centre must include a training undertaking as part of its activities.
Please review the detailed Guidelines for further information about eligibility and the application process. All submissions must be made through SmartyGrants with a link provided below. The sample EOI application form provides an overview of what is required in your EOI.
Submissions will close at 16:00 AEDT on 15 March 2021.
Listen to the MTPConnect Podcast to learn more about this funding opportunity.